Democritus University of Thrace (DUTH)
Η επίδραση της παρεντερικής χορήγησης αμινοξέων στην οξεοβασική ισορροπία ασθενών με επιβάρυνση της νεφρικής λειτουργίας
Abstract
dc:descriptionSUMMARYEffect of parenteral infusion of amino-acids on acid-base balance in patients with chronic renal failureEirini M. KalogiannidouPatients with chronic kidney disease (CKD), before they reach to the end-stage, as well as when they are haemodialyzed, have many causes for experiencing malnutrition and negative nitrogen balance. Many studies showed that the syndrome of malnutrition from reduction intake of calories derived from proteins associated with reduced quality of life, especially of cardiovascular disorders. Epidemiological studies have shown that the hypoalbuminaemia is common among dialyzed patients and it is a strong predictor of poor outcome in patients with end-stage CKD. The administration of amino acids in such cases has been the subject of many studies which have showed that they contribute positively to the evolution of these patients.The aim of this study was to investigate whether parenteral administration of amino acids affects the acid-base balance in patients with CKD, in which it is assumed that the possibility of neutralization of acids is reduced due to the reduction of alkaline deposit (decreased levels of Hb, albumin, hyperparathyroidism) and decreased renal function (reduced ability to produce ammonium and titratable acid excretion).We studied 25 patients (12F, 13M), aged 37-85 years (median 73 years) with CKD stage 3rd and 4th with GFR ranged from 16 to 45,1 ml/min (mean±SD=26,6±8,1 ml/min). The cause of renal diseases were diabetic nephropathy in 11, hypertensive nephrosclerosis in 7, polycystic kidney disease in 2, eclampsia in 1 and unknown nephropathy in 4.We studied also 107 hemodialyzed patients (52F, 55M) aged 30-92 years (median=73 years), treated with specific for uremic patients amino acid solution and 47 others (18F, 29M), aged 33-90 years (median=74 years), treated with non-specific amino acid solution. The 86 of the 107 patients treated with the specific amino acid solution did haemodialyzed with conventional bicarbonate dialysis and the rest 21 with on-line hemodiafiltration, while from those treated with non-specific solution, the 37 out of the 47 patients received conventional bicarbonate dialysis and the rest 10 on-line hemodiafiltration. Excluded from the study patients with infection (clinicaly and laboratory proven) as well as those with elevated serum lactate levels.In the groups of the study patients were evaluated all the parameters of acid-base balance as follows: a) patients with 3rd or 4th stage of CKD before and after the administration of amino acids for 5 days and b) haemodialyzed patients, before and after the administration of amino acids, as well as after 44 hours of the last dose.The results regarding patients of 3rd and 4th stages revealed the following: blood pH did not show any statistically significant difference between the first infusion and immediately after the end of the infusion of the specific solution (7,34±0,04 Vs 7,32±0,06, p=NS), in contrast to the non-specific solution where the administration caused a significant decrease in pH (7,34±0,05 Vs 7,30±0,06, p=0,0001). This difference was due to the reduction of HCO3- which was statistically significant for both solutions which were administered (for the specific solution 18,38±3,17 Vs 16,98±3,76, p=0,0001 and for the non-specific solution 19,38±3,24 Vs 15,59±3,6, p=0,0001), despite the fact that the difference in the last sample was greater with the non-specific solution (specific versus non-specific solution 16,98±3,76 Vs 15,59±3,6, p=0,026). Differences in PaCO2 observed due to the different decompensation that had to be achieved.The statistical analysis of the results of hemodialyzed patients showed that the specific solution improved pH (it was more alkalotic after 44 hours from the end of dialysis session), whereas with the non-specific solution the pH was not significantly different compared to the initial value. Respectively with the special solution HCO3- increased after 44 hours of the end of the session, while with the non-specific solution is was not changed from the initial value. Finally PaCO2 not changed significantly with both infusions (with specific and non-specific solution).But how could we explain the different effect of amino acid solutions on the acid-base balance? The first is that the non-specific solution, containing high concentrations of CI-, which apparently is responsible for acidosis. A second cause is that there was an important difference between the solutions in the containing of significant quantities of precursors of HCO3-, such as the acetates and maleineic (they were in the specific but not in the non-specific solution). Finally the specific solution contains base (NaOH), which has a protective role against acidosis. About the content of amino acids with sulfate groups, the solutions of our study contained equivalent amount of cysteine, so the metabolic products (sulfate radicals) was expected to be correspondingly and thus that could not be responsible for varying degrees of deterioration of metabolic acidosis. Finally, the content of the solutions to glutamine and aspartic acid (anionic amino acids, which are metabolized consuming H+) were in small quantities in the non-specific solution. Obviously, the main differences between the two amino acid solutions which were used was the content of CI-, NaOH and acetates and perhaps to the methionine, resulting in the specific only solution to protect against causing metabolic acidosis.But why solutions of amino acids containing CI-, since it is responsible for metabolic acidosis at least in some patients? This is due to the fact that the preparation of solutions for parenteral nutrition is that the pH of the solution is the lowest possible, to prevent the reaction Maillard's (i.e., the reaction of glucose with amino acids-caramelization, which is accelerated in an alkaline environment).Our study found that: a) the kind of amino acid solutions that must be administered in patients with CKD are important, because they could accelerate metabolic acidosis or not, b) the specific for uremic patients amino acids solutions should be preferred because they improve the pH due to increase of the HCO3-) and c) the content of specific solutions in acetate or precursors of HCO3- (maleineic) and NaOH plays a special role in the prevention of acidosis.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kalogiannidou, Eirini
- Καλογιαννίδου, Ειρήνη
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34587